file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
1201 | PHARMACOKINETIC | 3 | 4 | 86 |
1202 | PROBALE | 1 | 0 | 86 |
1203 | RUPTURE | 4 | 5 | 86 |
1204 | T-TUBE | 1 | 34 | 86 |
1205 | THORACIC-DUCT | 4 | 26 | 86 |
1206 | VARIATIONS | 1 | 3 | 86 |
1207 | DETECTED | 2 | 39 | 85 |
1208 | EVENT | 3 | 15 | 85 |
1209 | HISTOPATHOLOGICAL | 5 | 4 | 85 |
1210 | NEUTROPHILS | 4 | 5 | 85 |
1211 | SWINE | 4 | 13 | 85 |
1212 | BRAIN | 3 | 1 | 84 |
1213 | INVOLVED | 2 | 1 | 84 |
1214 | MEASUREMENTS | 2 | 8 | 84 |
1215 | PRESENTING | 5 | 3 | 84 |
1216 | RATES | 3 | 5 | 84 |
1217 | REDUCTION | 4 | 11 | 84 |
1218 | ALTERNATIVE | 5 | 2 | 83 |
1219 | CONTRIBUTION | 7 | 2 | 83 |
1220 | ESTABLISHMENT | 6 | 40 | 83 |
1221 | MACROLIDE | 2 | 0 | 83 |
1222 | PARADIGM | 8 | 17 | 83 |
1223 | PHENOTYPE | 3 | 27 | 83 |
1224 | SIGNALING | 3 | 4 | 83 |
1225 | TOPICS | 2 | 23 | 83 |
1226 | ANTIDONOR | 3 | 33 | 82 |
1227 | EXTRACELLULAR | 2 | 3 | 82 |
1228 | HIGH-DOSE | 4 | 32 | 82 |
1229 | HISTOINCOMPATIBILITY | 1 | 25 | 82 |
1230 | IMMATURE | 3 | 18 | 82 |
# | Word | Recs | TLCS | TGCS |
1231 | LYMPHOBLASTS | 2 | 30 | 82 |
1232 | MINIATURE | 3 | 13 | 82 |
1233 | PRIOR | 5 | 6 | 82 |
1234 | ANTI-SERUM | 1 | 30 | 81 |
1235 | BIOMEDICAL | 1 | 13 | 81 |
1236 | COLORADO-PITTSBURGH | 1 | 13 | 81 |
1237 | CYCLOSPORINE-STEROID | 2 | 11 | 81 |
1238 | DIABETIC-PATIENTS | 3 | 5 | 81 |
1239 | EFFLUX | 2 | 1 | 81 |
1240 | MORBIDITY | 4 | 9 | 81 |
1241 | ORGAN-SPECIFIC | 2 | 25 | 81 |
1242 | TWO | 5 | 0 | 81 |
1243 | ANTIBLAST | 1 | 6 | 80 |
1244 | CHEMOTAXIS | 1 | 0 | 80 |
1245 | CRUSHED | 1 | 8 | 80 |
1246 | CYSTEINYL | 1 | 0 | 80 |
1247 | DAYS | 3 | 11 | 80 |
1248 | EMPHASIS | 4 | 18 | 80 |
1249 | FEASIBLE | 2 | 22 | 80 |
1250 | FULLY | 4 | 9 | 80 |
1251 | LEUKOTRIENE-DEPENDENT | 1 | 0 | 80 |
1252 | LICHEN | 1 | 0 | 80 |
1253 | PLANUS | 1 | 0 | 80 |
1254 | STIMULATES | 1 | 0 | 80 |
1255 | TRANSPORTER-AND | 1 | 0 | 80 |
1256 | HYPOREACTIVITY | 4 | 28 | 79 |
1257 | IMMUNE-RESPONSE | 2 | 6 | 79 |
1258 | PARTIAL | 8 | 10 | 79 |
1259 | PROTOCOL | 5 | 15 | 79 |
1260 | SYNTHETIC | 3 | 1 | 79 |
# | Word | Recs | TLCS | TGCS |
1261 | TERM | 5 | 22 | 79 |
1262 | ALTERNATIVES | 2 | 5 | 78 |
1263 | BILE-ACID | 2 | 2 | 78 |
1264 | CORNEAL | 6 | 6 | 78 |
1265 | EXTRAHEPATIC | 2 | 20 | 78 |
1266 | IMMUNOGLOBULIN | 5 | 5 | 78 |
1267 | THREE | 5 | 10 | 78 |
1268 | AMELIORATES | 3 | 9 | 77 |
1269 | BRIEF | 3 | 18 | 77 |
1270 | COHORT | 2 | 0 | 77 |
1271 | LABORATORY | 6 | 0 | 77 |
1272 | MICRODISSECTION | 2 | 5 | 77 |
1273 | MODIFICATION | 7 | 4 | 77 |
1274 | RECONSTITUTION | 5 | 47 | 77 |
1275 | UNIVERSITY | 5 | 13 | 77 |
1276 | 6-MERCAPTOPURINE | 4 | 10 | 76 |
1277 | AFFECT | 5 | 12 | 76 |
1278 | BRONCHIOLITIS | 6 | 3 | 76 |
1279 | CHIMERAS | 6 | 9 | 76 |
1280 | CLINICAL-RESULTS | 3 | 4 | 76 |
1281 | DISAPPEARANCE | 1 | 5 | 76 |
1282 | HUMAN-KIDNEY | 3 | 1 | 76 |
1283 | INCREASE | 3 | 0 | 76 |
1284 | INTERMITTENT | 1 | 5 | 76 |
1285 | INTRAVENOUSLY | 1 | 5 | 76 |
1286 | OBLITERANS | 5 | 3 | 76 |
1287 | SHORT-COURSE | 3 | 30 | 76 |
1288 | SOLUBLE | 9 | 10 | 76 |
1289 | BACTERIAL | 2 | 1 | 75 |
1290 | CHARACTERISTICS | 4 | 5 | 75 |
# | Word | Recs | TLCS | TGCS |
1291 | CONTRIBUTIONS | 3 | 23 | 75 |
1292 | CRITICAL | 5 | 14 | 75 |
1293 | DEMONSTRATED | 2 | 6 | 75 |
1294 | INTERPRETATION | 2 | 4 | 75 |
1295 | LYMPHOID-TISSUES | 2 | 49 | 75 |
1296 | MODE | 6 | 17 | 75 |
1297 | TWELVE | 1 | 21 | 75 |
1298 | USES | 6 | 23 | 75 |
1299 | VIRUS-POSITIVE | 1 | 3 | 75 |
1300 | ACHIEVEMENT | 3 | 34 | 74 |
1301 | BABY | 2 | 3 | 74 |
1302 | CESSATION | 2 | 8 | 74 |
1303 | CLEAR | 1 | 30 | 74 |
1304 | INFILTRATES | 2 | 2 | 74 |
1305 | IRRADIATED | 5 | 46 | 74 |
1306 | LOW | 9 | 6 | 74 |
1307 | ORTHOCLONE | 2 | 4 | 74 |
1308 | RADIOISOTOPIC | 1 | 8 | 74 |
1309 | SEGMENTAL | 2 | 5 | 74 |
1310 | SURGERY | 11 | 1 | 74 |
1311 | ANIMALS | 4 | 11 | 73 |
1312 | AUTOTRANSPLANTATION | 3 | 6 | 73 |
1313 | COMPROMISED | 1 | 0 | 73 |
1314 | DEFENSE-MECHANISMS | 1 | 0 | 73 |
1315 | DISCONTINUATION | 1 | 5 | 73 |
1316 | ENDOTHELIAL-CELL | 1 | 6 | 73 |
1317 | HYPOTHERMIA | 4 | 1 | 73 |
1318 | MANIFESTATIONS | 1 | 0 | 73 |
1319 | MEDROXYPROGESTERONE | 2 | 3 | 73 |
1320 | ONGOING | 5 | 5 | 73 |
# | Word | Recs | TLCS | TGCS |
1321 | PITTSBURGH | 3 | 24 | 73 |
1322 | PULMONARY-DISEASES | 1 | 0 | 73 |
1323 | RECURRENCE | 4 | 17 | 73 |
1324 | ROENTGENOGRAPHIC | 1 | 0 | 73 |
1325 | SIBLINGS | 2 | 4 | 73 |
1326 | VASCULAR-RESISTANCE | 1 | 6 | 73 |
1327 | ALLERGY | 2 | 3 | 72 |
1328 | BILE-DUCT | 1 | 13 | 72 |
1329 | ENZYME-IMMUNOASSAY | 2 | 9 | 72 |
1330 | EXTRACORPOREAL | 4 | 2 | 72 |
1331 | MICROPARTICLE | 2 | 9 | 72 |
1332 | MICROVASCULAR | 3 | 7 | 72 |
1333 | NUMBERS | 4 | 7 | 72 |
1334 | OPPOSITE | 1 | 18 | 72 |
1335 | SCLEROSING | 1 | 2 | 72 |
1336 | VANISHING | 1 | 13 | 72 |
1337 | COMA | 1 | 1 | 71 |
1338 | CROSS | 1 | 1 | 71 |
1339 | IL-12 | 2 | 2 | 71 |
1340 | INTERSTITIAL | 3 | 5 | 71 |
1341 | LIVER-AND-KIDNEY | 1 | 3 | 71 |
1342 | PARAMETER | 2 | 3 | 71 |
1343 | PARTNERS | 1 | 1 | 71 |
1344 | PATHOGENETIC | 1 | 21 | 71 |
1345 | PEANUT | 1 | 3 | 71 |
1346 | PROGRESSION | 4 | 16 | 71 |
1347 | RAT-HEART | 3 | 4 | 71 |
1348 | STELLATE | 2 | 2 | 71 |
1349 | STR-ANALYSIS | 1 | 5 | 71 |
1350 | SYMPTOMATIC | 1 | 3 | 71 |
# | Word | Recs | TLCS | TGCS |
1351 | ADJUNCT | 4 | 45 | 70 |
1352 | ANTAGONISM | 2 | 10 | 70 |
1353 | BILIARY-EXCRETION | 1 | 1 | 70 |
1354 | DAMAGE | 7 | 5 | 70 |
1355 | ENHANCEMENT | 3 | 20 | 70 |
1356 | EXPERIMENTAL-MODELS | 1 | 9 | 70 |
1357 | HEPATOTROPHIC | 2 | 15 | 70 |
1358 | INDUCIBLE | 3 | 0 | 70 |
1359 | MICROSCOPIC | 4 | 20 | 70 |
1360 | NEED | 3 | 21 | 70 |
1361 | PERSISTENT | 3 | 3 | 70 |
1362 | PRIMARILY | 2 | 6 | 70 |
1363 | T-CELL-MEDIATED | 3 | 2 | 70 |
1364 | TOOL | 4 | 13 | 70 |
1365 | ULTRASTRUCTURAL | 2 | 12 | 70 |
1366 | VALUE | 10 | 4 | 70 |
1367 | XENOGRAFT | 6 | 9 | 70 |
1368 | ARTERIOGRAPHY | 2 | 7 | 69 |
1369 | BIOLOGICAL | 5 | 13 | 69 |
1370 | BLEEDING | 3 | 6 | 69 |
1371 | COMPOUNDS | 3 | 5 | 69 |
1372 | FACIAL | 2 | 3 | 69 |
1373 | FORMULATION | 2 | 1 | 69 |
1374 | HISTOLOGICAL | 4 | 8 | 69 |
1375 | IMMUNOGENICITY | 4 | 15 | 69 |
1376 | ISCHEMIC | 3 | 1 | 69 |
1377 | PCR-FLOW | 1 | 34 | 69 |
1378 | POST-TRANSPLANTATION | 4 | 4 | 69 |
1379 | SEQUENCE-SPECIFIC | 3 | 16 | 69 |
1380 | ALPHA | 4 | 10 | 68 |
# | Word | Recs | TLCS | TGCS |
1381 | ANTIGEN-PRESENTING | 2 | 23 | 68 |
1382 | BLOOD-TRANSFUSION | 7 | 6 | 68 |
1383 | CONCEPT | 3 | 29 | 68 |
1384 | DISRUPTION | 1 | 23 | 68 |
1385 | DOWN-REGULATION | 3 | 3 | 68 |
1386 | ENLARGEMENT | 3 | 10 | 68 |
1387 | EXPLORATION | 1 | 4 | 68 |
1388 | FIBROSIS | 2 | 3 | 68 |
1389 | FORMAL | 1 | 4 | 68 |
1390 | GENETIC | 6 | 1 | 68 |
1391 | IMPROVEMENT | 1 | 18 | 68 |
1392 | ISSUES | 4 | 0 | 68 |
1393 | KIDNEY-FUNCTION | 1 | 18 | 68 |
1394 | MACROLACTAMIZATION | 1 | 4 | 68 |
1395 | MAINTAINED | 3 | 1 | 68 |
1396 | OBLITERATIVE | 2 | 23 | 68 |
1397 | OPINIONS | 1 | 4 | 68 |
1398 | PTLD | 2 | 2 | 68 |
1399 | RECRUITMENT | 2 | 1 | 68 |
1400 | RESISTANT | 3 | 13 | 68 |